Skip to content
Magazine
Tuesday, August 5, 2025
SUBSCRIBE
  • About Us
  • Belgium News
    • Belgium Police News
    • Brussels News
  • EU Institutions News
    • European Commission News
    • European Parliament News
    • European Council News
  • Europe News
  • World News
  • Belgium Business News
  • Culture and Society News
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
  • About Us
  • Belgium News
    • Belgium Police News
    • Brussels News
  • EU Institutions News
    • European Commission News
    • European Parliament News
    • European Council News
  • Europe News
  • World News
  • Belgium Business News
  • Culture and Society News
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
SUBSCRIBE

Novavax vaccine greenlit for use in Belgium

Sarhan Basem by Sarhan Basem
19 January 2022
in Belgium News
Gaithersburg,,Ma,,Usa,,February,5th,2021:,A,Syringe,Next,To

Gaithersburg, MA, USA, february 5th 2021: A syringe next to the Novavax Covid-19 vaccine box isolated on a white background. Health and prevention.

Brussels (Brussels Morning)Health ministers have given the green light to use Novavax’s Nuvaxovid vaccine as an alternative for people who have not yet been vaccinated. This primarily concerns people with a high risk of allergic reactions to the available vaccines or people who had side effects after a first vaccination against Covid-19.

This was reported by the Interministerial Conference (IMC) for Public Health on Wednesday. Nuvaxovid is the vaccine from the American Novavax. The vaccine received the green light from the European Medicines Agency (EMA) in December 2021. This made it the fifth vaccine to be approved in Europe.

Nuvaxovid is a so-called protein vaccine that works differently from the mRNA vaccines from Pfizer and Moderna. It contains small particles that mimic the spike protein of the coronavirus, against which the body makes antibodies. The primary vaccination course with Nuvaxovid consists of two doses administered at least three weeks apart.

Alternative vaccine

The health ministers have now decided to use Novavax as an alternative vaccine. Primarily, it will target an estimated 3,000 people who have not yet been vaccinated because they were at high risk of allergic reactions to the components of the previously used vaccines and people who have experienced serious side effects after being vaccinated with those previous vaccines.

Because this concerns a limited group, the federal states can also offer the vaccine to other groups, according to the first come, first served principle. “This may include unvaccinated healthcare workers and individuals who have developed a phobia against the other vaccines, whose efficacy and safety have been extensively scientifically proven,” the IMC reports. The intention is to use the BruVax and QVax registration platforms.

From the second half of February 2022, 510,000 doses of Nuvaxovid will be delivered in our country, spread over the months of February and March. With this delivery, up to 170,000 people can be vaccinated. “We are anticipating that these people will also need a booster in the future, and are awaiting further scientific data for this,” it said according to a report by BRUZZ.

Related News:

  • Brussels will start offering Novavax vaccine on 1 March
  • COVID vaccine ready early next year, says UK vaccine chief
  • WTO head criticises EU’s vaccine export restrictions
  • German Ethics Council approves mandatory use of COVID-19 vaccine
Next Post
Mining,Machines,Operating,In,The,Turow,Lignite,Opencast,Mine,In

Czech Republic, Poland continue talks on Turów mine dispute

Latest post

EU-elections-UK

EU elections: UK looks on from the “outside”

1 year ago
Galeries-Royales-Saint-Hubert

What Makes Galeries Royales Saint-Hubert an “Institution”?

1 year ago

Most Read

    Follow Brussels Morning
    Facebook Twitter Youtube Linkedin

    Browse Important News

    Belgium News
    Brussels News
    Culture and Society News
    Economy News
    EU Institutions News
    European Commission News
    European Council News
    European Parliament News
    Europe News
    Health And Fitness News
    Southeast Europe News
    Sustainable Perspective
    World News
    Diplomacy News
    US Elections News

    About Us

    Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

    More Info

    • About Us
    • Advertise With Us
    • Contact Us
    • Cookies Policy

    Join Our Newsletter

    Brussels Morning Newspaper – All Rights Reserved © 2024

    No Result
    View All Result
    • Home
    • About Us
    • Belgium News
      • Belgium Police News
      • Brussels News
    • Brussels Bubble
      • European Parliament News
      • European Commission News
      • European Council News
    • Wider Europe
      • Member States
    • World News
    • Business & Society
    • Europe With Transparency
    • Culture & Society
    • Policy Talks
      • Place de la Bourse
      • The Macro-Economist
      • Sustainable Perspective
      • Ambassador’s Corner
      • The American Angle
      • Southeast Europe
    • Print Magazine

    Brussels Morning Newspaper - All Rights Reserved © 2020

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT